Lakeshore Biopharma Co logo

Lakeshore Biopharma Co Share Price (NASDAQ: LSB)

$0.8

Last updated on

Check the interactive Lakeshore Biopharma Co Stock chart to analyse performance

Lakeshore Biopharma Co Ltd Key Stats

Check Lakeshore Biopharma Co key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.8
Open
$0.765
Market Capitalization
$33.0M
Today's Volume
$181.4K
Revenue TTM
$615.0M
EBITDA
$-12.9M
Earnings Per Share (EPS)
$-0.73
Profit Margin
-16.26%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-18.43%

Stock Returns calculator for Lakeshore Biopharma Co Stock including INR - Dollar returns

The Lakeshore Biopharma Co stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lakeshore Biopharma Co investment value today

Current value as on today

₹23,062

Returns

₹76,938

(-76.94%)

Returns from Lakeshore Biopharma Co Stock

₹82,222 (-82.22%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Lakeshore Biopharma Co Stock

0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Lakeshore Biopharma Co Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Lakeshore Biopharma Co Stock

Rating
Trend

Lakeshore Biopharma Co Share Price Target

What analysts predicted

Upside of 423.75%

Target:

$4.19

Current:

$0.80

Lakeshore Biopharma Co share price target is $4.19, a slight Upside of 423.75% compared to current price of $0.80 as per analysts' prediction.

Lakeshore Biopharma Co Stock Insights

  • Price Movement

    In the last 3 months, LSB stock has moved down by -25.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 168.70M → 135.52M (in $), with an average decrease of 19.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -80.15M → -181.41M (in $), with an average decrease of 126.3% per quarter
  • LSB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 151.8%
  • Price to Sales

    ForLSB every $1 of sales, investors are willing to pay $0.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Lakeshore Biopharma Co Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY21
FY22
FY23
FY24
FY25
FY25Y/Y Change
Revenue
$84.8M
↑ 7.24%
Net Income
$-13.8M
↓ 76.93%
Net Profit Margin
-16.26%
↑ 59.33%

Lakeshore Biopharma Co Technicals Summary

Sell

Neutral

Buy

Lakeshore Biopharma Co is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lakeshore Biopharma Co Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lakeshore Biopharma Co Ltd logo
-2.44%
-61.72%
-82.22%
-92.08%
-92.08%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Lakeshore Biopharma Co Ltd

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.
Organization
Lakeshore Biopharma Co
Employees
758
CEO
Mr. Wang Xu
Industry
Miscellaneous

Key Management of Lakeshore Biopharma Co Ltd

NameTitle
Dr. Yuan Liu Ph.D.
Head of Vaccine Research
Mr. Wang Xu
CEO & Director
Dr. Hui Shao C.F.A., M.B.A., Ph.D.
President, Chief Business Officer & Vice Chairman
Ms. Rui Yu M.B.A., M.S.
CFO & Director
Ms. Zhiyuan Ran
Head of Marketing and Sales
Dr. Honggang Teng
Head of Production & Quality Management

Important FAQs about investing in LSB Stock from India :

What is Lakeshore Biopharma Co share price today?

Lakeshore Biopharma Co share price today is $0.80 as on at the close of the market. Lakeshore Biopharma Co share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Lakeshore Biopharma Co share?

Lakeshore Biopharma Co share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Lakeshore Biopharma Co stock price today i.e. is closed at $0.80, lower by 90.7% versus the 52 week high.

How to invest in Lakeshore Biopharma Co Stock (LSB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lakeshore Biopharma Co on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lakeshore Biopharma Co Shares that will get you 1.8750 shares as per Lakeshore Biopharma Co share price of $0.80 per share as on August 30, 2025 at 1:25 am IST.

What is the minimum amount required to buy Lakeshore Biopharma Co Stock (LSB) from India?

Indian investors can start investing in Lakeshore Biopharma Co (LSB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Lakeshore Biopharma Co stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Lakeshore Biopharma Co share’s latest price of $0.80 as on August 30, 2025 at 1:25 am IST, you will get 12.5000 shares of Lakeshore Biopharma Co. Learn more about fractional shares .

What are the returns that Lakeshore Biopharma Co has given to Indian investors in the last 5 years?

Lakeshore Biopharma Co stock has given -92.08% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?